Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an ...

The one-time leader of the DNA analysis market – valued at $6 billion in 2021 – is now worth less than $100 million, a 99 ...

Ms. Wojcicki, or more exactly the Anne Wojcicki Revocable Trust, is backed in this take-private transaction by New Mountain Capital, with her legal advice from heavyweight law firm Skadden Arps Slate ...

Anne Wojcicki’s decision to take 23andMe private with the backing of New Mountain Capital marks a crucial moment in the ...

Me (NASDAQ:ME) co-founder and CEO Anne Wojcicki and private equity firm New Mountain Capital offered to purchase the genetic testing company for $2.53 a share in cash. 23andME rose 5% in after hours ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private. They are offering to buy all outstanding shares in cash for $2.53 per share, or an equity ...